Disturbances of lipoprotein metabolism in metabolic syndrome;Zaburzenia metabolizmu lipoprotein w zespole metabolicznym

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 64, Issue , 2010, Pages 1-10

  Czyzewska, Marta ^a   Wolska, Anna ^a   Ćwiklińska, Agnieszka ^a   Kortas Stempak, Barbara ^a   Wróblewska, Małgorzata ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Atherogenic triad; Insulin resistance; Metabolic syndrome; Small dense LDL; VLDL overproduction

Indexed keywords

LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

HUMAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; METABOLISM; PHYSIOLOGY; POSTPRANDIAL STATE; REVIEW;

CHOLESTEROL, VLDL; HUMANS; INSULIN RESISTANCE; LIPOPROTEINS; METABOLIC SYNDROME X; POSTPRANDIAL PERIOD;

EID: 77950376513     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Adeli K., Lewis G. F.: Intestinal lipoprotein overproduction in insulinresistant states. Curr. Opin. Lipidol., 2008;19:221-228 (Pubitemid 351653558)
2. Adiels M., Olofsson S. O., Taskinen M. R., Borén J.: Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler. Thromb. Vasc. Biol., 2008;28:1225-1236
3. Adiels M., Taskinen M. R., Borén J.: Fatty liver, insulin resistance, and dyslipidemia. Curr. Diab. Rep., 2008;8:60-64 (Pubitemid 351384877)
4. Adiels M., Taskinen M. R., Packard C., Caslake M. J., Soro-Paavonen A., Westerbacka J., Vehkavaara S., Häkkinen A., Olofsson S. O., Yki-Järvinen H., Borén J.: Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia, 2006;49:755-765 (Pubitemid 43357551)
5. 1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia, 2007;50:2356-2365 (Pubitemid 47512396)
6. Alberti K. G., Zimmet P. Z.: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med., 1998;15:539-553 (Pubitemid 28319935)
7. Arner P.: The role of adipose tissue in lipoprotein metabolism. Atherosclerosis, 1999;146(Suppl. 1):S11-S12 (Pubitemid 29406129)
8. Asztalos B. F., Schaefer E. J., Horvath K. V., Yamashita S., Miller M., Franceschini G., Calabresi L.: Role of LCAT in HDL remodeling: investigation of LCAT deficiency states. J. Lipid. Res., 2007;48:592-599 (Pubitemid 46397462)
9. Austin M. A., King M. C., Vranizan K. M., Krauss R. M.: Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation, 1990;82:495-506 (Pubitemid 20257828)
10. Badellino K. O., Wolfe M. L., Reilly M. P., Rader D. J.: Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis. PLoS Med., 2006;3:e22
11. Barrows B. R., Parks E. J.: Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. J. Clin. Endocrinol. Metab., 2006;91:1446-1452
12. Barter P. J.: Hugh Sinclair lecture: the regulation and remodelling of HDL by plasma factors. Atherosclerosis Suppl., 2002;3:39-47 (Pubitemid 38234485)
13. Barter P. J., Ballantyne C. M., Carmena R., Castro Cabezas M., Chapman M. J., Couture P., de Graaf J., Durrington P. N., Faergeman O., Frohlich J., Furberg C. D., Gagne C., Haffner S. M., Humphries S. E., Jungner I., Krauss R. M., Kwiterovich P., Marcovina S., Packard C. J., Pearson T. A., Reddy K. S., Rosenson R., Sarrafzadegan N., Sniderman A. D., Stalenhoef A. F., Stein E., Talmud P. J., Tonkin A. M., Walldius G., Williams K. M.: Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J. Intern. Med., 2006;259:247-258
14. Berneis K. K., Krauss R. M.: Metabolic origins and clinical significance of LDL heterogeneity. J. Lipid Res., 2002;43:1363-1379
15. Björkegren J., Packard C. J., Hamsten A., Bedford D., Caslake M., Foster L., Shepherd J., Stewart P., Karpe F.: Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway. J. Lipid Res., 1996;37:76-86 (Pubitemid 26052621)
16. Blades B., Vega G. L., Grundy S. M.: Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler. Thromb. Vasc. Biol., 1993;13:1227-1235 (Pubitemid 23239921)
17. Carr M. C., Brunzell J. D.: Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J. Clin. Endocrinol. Metab., 2004;89:2601-2607 (Pubitemid 38766338)
18. Cohn J. S., Patterson B. W., Uffelman K. D., Davignon J., Steiner G.: Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity. J. Clin. Endocrinol. Metab., 2004;89:3949-3955 (Pubitemid 39071498)
19. Connelly P. W.: The role of hepatic lipase in lipoprotein metabolism. Clin. Chim. Acta, 1999;286:243-255 (Pubitemid 29406112)
20. Cooper A. D.: Hepatic uptake of chylomicron remnants. J. Lipid Res., 1997;38:2173-2192 (Pubitemid 27495377)
21. Davis R. A.: Cell and molecular biology of the assembly and secretion of apolipoprotein B-containing lipoproteins by the liver. Biochim. Biophys. Acta, 1999;1440:1-31 (Pubitemid 29406146)
22. Donnelly K. L., Smith C. I., Schwarzenberg S. J., Jessurun J., Boldt M. D., Parks E. J.: Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest., 2005;115:1343-1351 (Pubitemid 40629054)
23. Duez H., Pavlic M., Lewis G. F.: Mechanism of intestinal lipoprotein overproduction in insulin resistant humans. Atherosclerosis Suppl., 2008;9:33-38
24. Ferré P., Foufelle F.: SREBP-1c transcription factor and lipid homeostasis: clinical perspective. Horm. Res., 2007;68:72-82 (Pubitemid 47026704)
25. Fielding B. A., Frayn K. N.: Lipoprotein lipase and the disposition of dietary fatty acids. Br. J. Nutr., 1998;80:495-502 (Pubitemid 29060530)
26. Galton D. J., Wallis S.: The regulation of adipose cell metabolism. Proc. Nutr. Soc, 1982;41:167-173
27. Ginsberg H. N., Zhang Y. L., Hernandez-Ono A.: Regulation of plasma triglycerides in insulin resistance and diabetes. Arch. Med. Res., 2005;36:232-240 (Pubitemid 40755136)
28. Ginsberg H. N., Zhang Y. L., Hernandez-Ono A.: Metabolic syndrome: focus on dyslipidemia. Obesity, 2006;14(Suppl. 1):41S-49S
29. Goldberg I. J.: Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J. Lipid Res., 1996;37:693-707 (Pubitemid 26140808)
30. Grundy S. M.: Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am. J. Cardiol., 1998;81:18B-25B (Pubitemid 28113941)
31. Grundy S. M.: Non-high-density lipoprotein cholesterol level as potential risk predictor and therapy target. Arch. Intern. Med., 2001;161:1379-1380 (Pubitemid 32681157)
32. Grundy S. M., Brewer H. B. Jr., Cleeman J. I., Smith S. C. Jr., Lenfant C.: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation, 2004;109:433-438 (Pubitemid 38133916)
33. Guérin M., Le Goff W., Lassel T. S., Van Tol A., Steiner G., Chapman M. J.: Proatherogenic role of elevated CE transfer from HDL to VLDL1 and dense LDL in type 2 diabetes: impact of the degree of triglyceridemia. Arterioscler. Thromb. Vasc. Biol., 2001;21:282-288 (Pubitemid 32125379)
34. Haffner S. M., Mykkänen L., Festa A., Burke J. P., Stern M. P.: Insulinresistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation, 2000;101:975-980 (Pubitemid 30131698)
35. Haidari M., Leung N., Mahbub F., Uffelman K. D., Kohen-Avramoglu R., Lewis G. F., Adeli K.: Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction. J. Biol. Chem., 2002, 277:31646-31655 (Pubitemid 34968968)
36. Hirano T., Nohtomi K., Sato Y., Kamata K., Ito Y.: Small dense LDL-cholesterol determined by a simple precipitation assay for screening familial combined hyperlipidemia. Atherosclerosis, 2009;205:603-607
37. Iizuka K., Horikawa Y.: ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome. Endocr. J., 2008;55:617-624
38. International Diabetes Federation. The IDF consensus worldwide defnition of the metabolic syndrome. April 14, 2005. http://www.idf.org/webdata/docs/ Metac-syndrome-def.pdf (05.05.2009)
39. Jahangiri A., Rader D. J., Marchadier D., Curtiss L. K., Bonnet D. J., Rye K. A.: Evidence that endothelial lipase remodels high density lipoproteins without mediating the dissociation of apolipoprotein A-I. J. Lipid Res., 2005;46:896-903
40. Jaye M., Krawiec J.: Endothelial lipase and HDL metabolism. Curr. Opin. Lipidol., 2004;15:183-189 (Pubitemid 38453405)
41. Jaye M., Lynch K. J., Krawiec J., Marchadier D., Maugeais C., Doan K., South V., Amin D., Perrone M., Rader D. J.: A novel endothelialderived lipase that modulates HDL metabolism. Nat. Genet., 1999;21:424-428 (Pubitemid 29159582)
42. Lamarche B., Paradis M. E.: Endothelial lipase and the metabolic syndrome. Curr. Opin. Lipidol., 2007;18:298-303 (Pubitemid 46743054)
43. Lamarche B., Uffelman K. D., Carpentier A., Cohn J. S., Steiner G., Barrett P. H., Lewis G. F.: Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J. Clin. Invest., 1999;103:1191-1199 (Pubitemid 29207253)
44. Lewis G. F., Uffelman K. D., Szeto L. W., Weller B., Steiner G.: Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J. Clin. Invest., 1995;95:158-166
45. Lin M. C., Gordon D., Wetterau J. R.: Microsomal triglyceride transfer protein (MTP) regulation in HepG2 cells: insulin negatively regulates MTP gene expression. J. Lipid Res., 1995;36:1073-1081
46. Mann C. J., Yen F. T., Grant A. M., Bihain B. E.: Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J. Clin. Invest., 1991;88:2059-2066
47. Maugeais C., Tietge U. J., Broedl U. C., Marchadier D., Cain W., McCoy M. G., Lund-Katz S., Glick J. M., Rader D. J.: Dose-dependent acceleration of high-density lipoprotein catabolism by endothelial lipase. Circulation, 2003;108:2121-2126 (Pubitemid 37337589)
48. Mudd J. O., Borlaug B. A., Johnston P. V., Kral B. G., Rouf R., Blumenthal R. S., Kwiterovich P. O. Jr.: Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease. J. Am. Coll. Cardiol., 2007;50:1735-1741 (Pubitemid 47600586)
49. Murao K., Wada Y., Nakamura T., Taylor A. H., Mooradian A. D., Wong N. C.: Effects of glucose and insulin on rat apolipoprotein A-I gene expression. J. Biol. Chem., 1998;273:18959-18965 (Pubitemid 28366285)
50. Nagle C. A., Klett E. L., Coleman R. A.: Hepatic triacylglycerol accumulation and insulin resistance. J. Lipid Res., 2009;50(Suppl.):74-79
51. Nakamura T., Takano H., Umetani K., Kawabata K., Obata J., Kitta Y., Kodama Y., Mende A., Ichigi Y., Fujioka D., Saito Y., Kugiyama K.: Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome. Atherosclerosis, 2005;181:321-327 (Pubitemid 41019613)
52. Packard C. J.: Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem. Soc. Trans., 2003;31:1066-1069 (Pubitemid 37305047)
53. Packard C. J., Shepherd J.: Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler. Thromb. Vasc. Biol., 1997;17:3542-3556 (Pubitemid 28028567)
54. Panarotto D., Rémillard P., Bouffard L., Maheux P.: Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue-specific manner. Eur. J. Clin. Invest., 2002;32:84-92 (Pubitemid 36232728)
55. Paradis M. E., Badellino K. O., Rader D. J., Tchernof A., Richard C., Luu-The V., Deshaies Y., Bergeron J., Archer W. R., Couture P., Bergeron N., Lamarche B.: Visceral adiposity and endothelial lipase. J. Clin. Endocrinol. Metab., 2006;91:3538-3543 (Pubitemid 44402134)
56. Park Y., Grellner W. J., Harris W. S., Miles J. M.: A new method for the study of chylomicron kinetics in vivo. Am. J. Physiol. Endocrinol. Metab., 2000;279:E1258-E1263
57. Petersen K. F., Dufour S., Savage D. B., Bilz S., Solomon G., Yonemitsu S., Cline G. W., Befroy D., Zemany L., Kahn B. B., Papademetris X., Rothman D. L., Shulman G. I.: The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc. Natl. Acad. Sci. USA, 2007;104:12587-12594 (Pubitemid 47255198)
58. Pollare T., Vessby B., Lithell H.: Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. Arterioscler. Thromb. Vasc. Biol., 1991;11:1192-1203
59. Postic C., Girard J.: Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J. Clin. Invest., 2008;118:829-838 (Pubitemid 351364588)
60. Radeau T., Robb M., Lau P., Borthwick J., McPherson R.: Relationship of adipose tissue cholesteryl ester transfer protein (CETP) mRNA to plasma concentrations of CETP in man. Atherosclerosis, 1998;139:369-376 (Pubitemid 28361822)
61. Reaven G. M., Chen Y. D., Jeppesen J., Maheux P., Krauss R. M.: Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J. Clin. Invest., 1993;92:141-146 (Pubitemid 23208989)
62. Sandhofer A., Kaser S., Ritsch A., Laimer M., Engl J., Paulweber B., Patsch J. R., Ebenbichler C. F.: Cholesteryl ester transfer protein in metabolic syndrome. Obesity, 2006;14:812-818 (Pubitemid 46219722)
63. Shimomura I., Matsuda M., Hammer R. E., Bashmakov Y., Brown M. S., Goldstein J. L.: Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell, 2000;6:77-86
64. Sierra-Johnson J., Romero-Corral A., Somers V. K., Lopez-Jimenez F., Walldius G., Hamsten A., Hellénius M. L., Fisher R. M.: ApoB/ApoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects. Eur. Heart J., 2007, 28:2637-2643 (Pubitemid 350071512)
65. Sparks J. D., Sparks C. E.: Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biochim. Biophys. Acta, 1994;1215:9-32 (Pubitemid 24345052)
66. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation, 2002;106:3143-3421
67. Thuren T.: Hepatic lipase and HDL metabolism. Curr. Opin. Lipidol., 2000;11:277-283 (Pubitemid 30336025)
68. Uehara Y., Engel T., Li Z., Goepfert C., Rust S., Zhou X., Langer C., Schachtrup C., Wiekowski J., Lorkowski S., Assmann G., von Eckardstein A.: Polyunsaturated fatty acids and acetoacetate downregulate the expression of the ATP-binding cassette transporter A1. Diabetes, 2002;51:2922-2928
69. Van Greevenbroek M. M., de Bruin T. W.: Chylomicron synthesis by intestinal cells in vitro and in vivo. Atherosclerosis, 1998;141(Suppl. 1):S9-S16
70. Vedhachalam C., Duong P. T., Nickel M., Nguyen D., Dhanasekaran P., Saito H., Rothblat G. H., Lund-Katz S., Phillips M. C.: Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles. J. Biol. Chem., 2007;282:25123-25130 (Pubitemid 47347535)
71. Wang Y., Oram J. F.: Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a phospholipase D2 pathway. J. Biol. Chem., 2005;280:35896-35903 (Pubitemid 41633857)
72. Yamashita S., Hirano K., Sakai N., Matsuzawa Y.: Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein. Biochim. Biophys. Acta, 2000;1529:257-275
73. Zambon A., Bertocco S., Vitturi N., Polentarutti V., Vianello D., Crepaldi G.: Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins. Biochem. Soc. Trans., 2003;31:1070-1074 (Pubitemid 37305048)